Allianz Management Bets Big on Own Stock, But Jefferies Sees 23% Downside Ahead of Half-Year Results
Published on 07/14/2026 at 21:13 | Redaktion boerse-global.de
Allianz is buying back its own shares at a pace that far outstrips its scheduled timeline, yet one of Wall Street’s leading houses argues the stock is worth nearly a quarter less. The insurance giant’s €2.5bn buyback programme, launched on March 13, had already consumed 60% of the authorised volume by July 3 — with just 38% of the calendar elapsed. The accelerated repurchases have helped propel the equity to within 1.3% of its 52-week high, currently trading at €420.00. But Jefferies, which rates the stock a “Hold,” sets a target of just €325.00, implying a 23% downside from current levels.
The buyback has been gathering momentum in recent weeks. After touching a short-term low in mid-June, Allianz stepped up its purchases three weeks in a row. As of July 3, the company had acquired roughly 3.95 million shares, worth around €1.5bn. The programme, authorised in February, runs until the end of December 2026, but if the current tempo holds, the entire envelope could be deployed well ahead of schedule — a clear signal that management sees the stock as undervalued.
That view is not shared universally among analysts. Bankhaus Metzler recently lifted its price objective to €454.00, reaffirming a “Buy” rating and pointing to further upside. Jefferies, by contrast, stuck to its “Hold” stance with a €325.00 target, creating a €129.00 gap between the two houses — an unusually wide divergence for a DAX constituent. The disparity underscores the uncertainty surrounding Allianz’s valuation just as the market awaits the next set of earnings.
Should investors sell immediately? Or is it worth buying Allianz?
Separately, the company is losing a senior artificial-intelligence specialist. Stefan Weih, currently at Allianz Partners, will join Generali Deutschland on July 15 as Head of AI, Digitalization & Process Mining. The departure comes as Allianz itself pushes to harness AI for operational efficiency, making the exit a potential distraction in a key area of strategic focus.
Fundamentally, the insurer’s performance remains robust. In the first quarter of 2026, Allianz reported an operating result of €4.517bn, up 6.6% year on year. The solvency ratio stood at a comfortable 221%. Management has reiterated its full-year target of €17.4bn in operating profit, with a €1bn buffer on either side. For income-oriented investors, the stock also offers a dividend of €17.10 per share from the 2025 fiscal year, translating into a yield of 4.07% at the current price. Combined with the buyback, the total capital return for 2026 works out to at least 5.6%.
Technically, the shares are trading near overbought territory. The relative strength index sits at 68.6, edging toward the 70 threshold that often signals a pullback. The stock stands 6.71% above its 50-day moving average and 11.46% above the 200-day line. Over the past 12 months, Allianz has gained 21.28%, and at about €420.00 it is just 1.29% shy of the 52-week peak of €425.50 reached on July 10. From the 52-week trough of €334.90 set in August 2025, the advance amounts to 25.53%.
All eyes now turn to the half-year report, scheduled for August 7. The second-quarter numbers will test whether Allianz’s operational strength can justify the elevated share price — and perhaps narrow the chasm between the most optimistic and most pessimistic analyst forecasts. Until then, the weekly buyback disclosures will remain the primary gauge of how much conviction management has in its own equity.
Ad
Allianz Stock: New Analysis - 14 July
Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
